US 12234236
GLP-1R agonist and therapeutic method thereof
granted A61KA61K31/437A61P
Quick answer
US patent 12234236 (GLP-1R agonist and therapeutic method thereof) held by Ascletis Pharma (China) Co., Limited expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ascletis Pharma (China) Co., Limited
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/437, A61P, A61P3/04, A61P3/10